These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29908359)

  • 1. Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection.
    El Kamari V; Hileman CO; Gholam PM; Kulkarni M; Funderburg N; McComsey GA
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):536-542.e1. PubMed ID: 29908359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.
    Longenecker CT; Hileman CO; Funderburg NT; McComsey GA
    Clin Infect Dis; 2014 Oct; 59(8):1148-56. PubMed ID: 25015912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
    Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.
    Eckard AR; Jiang Y; Debanne SM; Funderburg NT; McComsey GA
    J Infect Dis; 2014 Apr; 209(8):1156-64. PubMed ID: 24415784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.
    Erlandson KM; Jiang Y; Debanne SM; McComsey GA
    Clin Infect Dis; 2015 Nov; 61(10):1566-72. PubMed ID: 26157049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy.
    Morrison JT; Longenecker CT; Mittelsteadt A; Jiang Y; Debanne SM; McComsey GA
    HIV Clin Trials; 2016 Jul; 17(4):140-6. PubMed ID: 27294339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of statin on arginine metabolites in treated HIV-infection.
    Dirajlal-Fargo S; El Kamari V; Sattar A; Alam K; Funderburg N; Labbato D; Pirro L; Longenecker CT; Wilson WH; McComsey GA
    Atherosclerosis; 2017 Nov; 266():74-80. PubMed ID: 28992467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    Longenecker CT; Sattar A; Gilkeson R; McComsey GA
    AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 96 Weeks of Rosuvastatin on Bone, Muscle, and Fat in HIV-Infected Adults on Effective Antiretroviral Therapy.
    Erlandson KM; Jiang Y; Debanne SM; McComsey GA
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):311-6. PubMed ID: 26477698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.
    Dirajlal-Fargo S; Kinley B; Jiang Y; Longenecker CT; Hileman CO; Debanne S; McComsey GA
    AIDS; 2015 Jan; 29(3):313-21. PubMed ID: 25686680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients.
    Calza L; Vanino E; Salvadori C; Manfredi R; Colangeli V; Cascavilla A; Di Bari MA; Motta R; Viale P
    HIV Clin Trials; 2014; 15(1):1-13. PubMed ID: 24518210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Selenium Concentrations Are Sufficient and Associated with Protease Inhibitor Use in Treated HIV-Infected Adults.
    Hileman CO; Dirajlal-Fargo S; Lam SK; Kumar J; Lacher C; Combs GF; McComsey GA
    J Nutr; 2015 Oct; 145(10):2293-9. PubMed ID: 26269240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
    Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
    Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maraviroc for previously treated patients with R5 HIV-1 infection.
    Gulick RM; Lalezari J; Goodrich J; Clumeck N; DeJesus E; Horban A; Nadler J; Clotet B; Karlsson A; Wohlfeiler M; Montana JB; McHale M; Sullivan J; Ridgway C; Felstead S; Dunne MW; van der Ryst E; Mayer H;
    N Engl J Med; 2008 Oct; 359(14):1429-41. PubMed ID: 18832244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Pericardial Fat Volume and Density on Markers of Insulin Resistance and Inflammation in Patients With Human Immunodeficiency Virus Infection.
    Longenecker CT; Margevicius S; Liu Y; Schluchter MD; Yun CH; Bezerra HG; McComsey GA
    Am J Cardiol; 2017 Oct; 120(8):1427-1433. PubMed ID: 28822563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.
    Rasmussen TA; McMahon JH; Chang JJ; Audsley J; Rhodes A; Tennakoon S; Dantanarayana A; Spelman T; Schmidt T; Kent SJ; Morcilla V; Palmer S; Elliott JH; Lewin SR
    Lancet HIV; 2018 May; 5(5):e221-e230. PubMed ID: 29643011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.
    Hileman CO; Tangpricha V; Sattar A; McComsey GA
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):539-547. PubMed ID: 28045766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial.
    Lee FJ; Monteiro P; Baker D; Bloch M; Roth N; Finlayson R; Moore R; Hoy J; Martinez E; Carr A
    HIV Med; 2016 Sep; 17(8):605-14. PubMed ID: 26987376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.